Overall, thesefindings suggest that uL3 could represent a valuablebiomarker for predicting tumor recurrence and patient outcome andthat regulating ABC gene expression could be convenientfor CRC therapy. The gene discussed is ABCB6; the disease is colorectal carcinoma.